UK markets open in 42 minutes
NIKKEI 225
38,124.02 -78.35 (-0.21%) HANG SENG
18,485.40 +171.54 (+0.94%) CRUDE OIL
79.41 +0.42 (+0.53%) GOLD FUTURES
2,322.90 +0.60 (+0.03%) DOW
39,056.39 +172.13 (+0.44%) Bitcoin GBP
49,423.25 -637.13 (-1.27%)
Bio-Rad Laboratories, Inc. (BUWA.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 08:20AM CEST. Market open.
| Previous close | 260.70 |
| Open | 259.50 |
| Bid | 249.50 x 5000 |
| Ask | 251.90 x 5000 |
| Day's range | 259.50 - 259.50 |
| 52-week range | 252.00 - 383.80 |
| Volume | |
| Avg. volume | 8 |
| Market cap | 7.38B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -20.26 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 856.25 |
ZacksBio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Down
Bio-Rad's (BIO) Clinical Diagnostics arm registers growth in Q1, primarily driven by an increased demand for quality control, blood typing, and diabetes products.
Insider MonkeyBio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript May 7, 2024 Bio-Rad Laboratories, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon everyone, and welcome to today’s Bio-Rad First Quarter 2024 Earnings Results Conference Call. At this […]
- Thomson Reuters StreetEvents
Q1 2024 Bio Rad Laboratories Inc Earnings Call
Q1 2024 Bio Rad Laboratories Inc Earnings Call
© 2024 Yahoo. All rights reserved.